24 related articles for article (PubMed ID: 9871756)
1. Synthesis and antimicrobial evaluation of nitazoxanide-based analogues: identification of selective and broad spectrum activity.
Ballard TE; Wang X; Olekhnovich I; Koerner T; Seymour C; Salamoun J; Warthan M; Hoffman PS; Macdonald TL
ChemMedChem; 2011 Feb; 6(2):362-77. PubMed ID: 21275058
[TBL] [Abstract][Full Text] [Related]
2. Clostridium difficile drug pipeline: challenges in discovery and development of new agents.
Jarrad AM; Karoli T; Blaskovich MA; Lyras D; Cooper MA
J Med Chem; 2015 Jul; 58(13):5164-85. PubMed ID: 25760275
[TBL] [Abstract][Full Text] [Related]
3. Anti-Helicobacter pylori agents. 3. 2-[(Arylalkyl)guanidino]-4-furylthiazoles.
Katsura Y; Nishino S; Ohno M; Sakane K; Matsumoto Y; Morinaga C; Ishikawa H; Takasugi H
J Med Chem; 1999 Jul; 42(15):2920-6. PubMed ID: 10425101
[TBL] [Abstract][Full Text] [Related]
4. Anti-Helicobacter pylori agents. 4. 2-(Substituted guanidino)-4-phenylthiazoles and some structurally rigid derivatives.
Katsura Y; Tomishi T; Inoue Y; Sakane K; Matsumoto Y; Morinaga C; Ishikawa H; Takasugi H
J Med Chem; 2000 Aug; 43(17):3315-21. PubMed ID: 10966750
[TBL] [Abstract][Full Text] [Related]
5. Anti-Helicobacter pylori agents. 5. 2-(Substituted guanidino)-4-arylthiazoles and aryloxazole analogues.
Katsura Y; Nishino S; Inoue Y; Sakane K; Matsumoto Y; Morinaga C; Ishikawa H; Takasugi H
J Med Chem; 2002 Jan; 45(1):143-50. PubMed ID: 11754586
[TBL] [Abstract][Full Text] [Related]
6. FR145715, a novel histamine H2 receptor antagonist, with specific anti-Helicobacter pylori activities.
Ishikawa H; Ito H; Higaki M; Higaki M; Matsumoto Y; Kamimura T; Katsura Y; Tomishi T; Inoue Y; Takasugi H; Tomoi M; Krakowka S; Yoshida K
Eur J Pharmacol; 1999 Aug; 378(3):299-310. PubMed ID: 10493106
[TBL] [Abstract][Full Text] [Related]
7. Studies on antiulcer drugs. VI. 4-Furyl-2-guanidinothiazoles and related compounds as potent histamine H2-receptor antagonists.
Katsura Y; Inoue Y; Tomishi T; Itoh H; Ishikawa H; Takasugi H
Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2432-41. PubMed ID: 1359931
[TBL] [Abstract][Full Text] [Related]
8. Anti-Helicobacter pylori agents. 2. Structure activity relationships in a new series of 2-alkylguanidino-4-furylthiazoles.
Katsura Y; Nishino S; Tomishi T; Sakane K; Matsumoto Y; Ishikawa H; Takasugi H
Bioorg Med Chem Lett; 1998 Jun; 8(11):1307-12. PubMed ID: 9871756
[TBL] [Abstract][Full Text] [Related]
9. Anti-Helicobacter pylori activities of ebrotidine. A review of biochemical and animal experimental studies and data.
Slomiany BL; Piotrowski J; Slomiany A
Arzneimittelforschung; 1997 Apr; 47(4A):475-82. PubMed ID: 9205747
[TBL] [Abstract][Full Text] [Related]
10. Histamine H2-antagonists--past, present and future.
Brittain RT; Jack D
J Clin Gastroenterol; 1983; 5 Suppl 1():71-9. PubMed ID: 6140285
[TBL] [Abstract][Full Text] [Related]
11. A review of the animal pharmacology of ranitidine--a new, selective histamine H2-antagonist.
Brittain RT; Daly MJ
Scand J Gastroenterol Suppl; 1981 Jun; 69():1-9. PubMed ID: 6119770
[TBL] [Abstract][Full Text] [Related]
12. Ebrotidine--a nostrum for ulcer.
Grover JK; Rathi SS; Vats V
Trop Gastroenterol; 1997; 18(3):111-3. PubMed ID: 9385853
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
